Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
[16] The reported incidence in the earlier literature varies from no neuropathy to over 90%. [1],4-8,20] This might be due to differences in patient selection or variation in the criteria used for ...
Peripheral neuropathy encompasses a variety of conditions marked by damage or lesions to peripheral nerves, resulting in symptoms such as pain, itch, and sensory disturbances. Diseases such as ...
Former Coronation Street star Lisa George reveals how being diagnosed with NAION (non-arteritic anterior ischemic optic neuropathy), a condition which can lead to sudden vision loss, left her ...